Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Second Line Metastatic Colorectal Cancer clinical trial (NCT01183780). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of ramucirumab and FOLFIRI work?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Second Line Metastatic Colorectal Cancer clinical trial (NCT01183780). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Second Line Metastatic Colorectal Cancer clinical trial (NCT01183780). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Second Line Metastatic Colorectal Cancer clinical trial (NCT01183780). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Second Line Metastatic Colorectal Cancer clinical trial (NCT01183780). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study in Second Line Metastatic Colorectal Cancer clinical trial (NCT01183780). Contact the study team or your healthcare provider for specific answers.

What this study is about